The purpose of this open-label, single arm, multi-center Expanded Treatment Protocol (ETP)
is to provide early access to ruxolitinib and evaluate safety information in patients with
PV, who are HU resistant or intolerant and who have no other standard treatment option, nor
do they qualify for another clinical study for PV.
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Novartis Investigative Site, A-1090 Vienna, Austria; Recruiting
Novartis Investigative Site, Innsbruck 6020, Austria; Withdrawn
Novartis Investigative Site, Linz 4010, Austria; Withdrawn
Novartis Investigative Site, Linz A-4010, Austria; Completed
Novartis Investigative Site, Linz A-4020, Austria; Recruiting
Novartis Investigative Site, Rankweil A-6830, Austria; Completed
Novartis Investigative Site, Salzburg 5020, Austria; Recruiting
Novartis Investigative Site, Wels A-4600, Austria; Recruiting
Novartis Investigative Site, Santiago 8420383, Chile; Not yet recruiting
Novartis Investigative Site, Santiago, Chile; Not yet recruiting
Novartis Investigative Site, Santiago, Chile; Withdrawn
Novartis Investigative Site, Viña del Mar 2540364, Chile; Not yet recruiting
Novartis Investigative Site, Medellín, Colombia; Withdrawn
Novartis Investigative Site, Monteria, Colombia; Withdrawn
Novartis Investigative Site, Angers Cedex 1 49033, France; Recruiting
Novartis Investigative Site, Bayonne 64109, France; Recruiting
Novartis Investigative Site, Bordeaux 33076, France; Not yet recruiting
Novartis Investigative Site, Brest 29200, France; Not yet recruiting
Novartis Investigative Site, Creteil 94010, France; Withdrawn
Novartis Investigative Site, Dunkerque 59240, France; Not yet recruiting
Novartis Investigative Site, Grenoble 38043, France; Withdrawn
Novartis Investigative Site, Marseille 13273, France; Recruiting
Novartis Investigative Site, Meaux cedex 77104, France; Recruiting
Novartis Investigative Site, Metz 57000, France; Recruiting
Novartis Investigative Site, Mulhouse cedex 68070, France; Not yet recruiting
Novartis Investigative Site, Nantes Cedex 1 44093, France; Not yet recruiting
Novartis Investigative Site, Nice Cedex 06202, France; Not yet recruiting
Novartis Investigative Site, Orleans 45100, France; Not yet recruiting
Novartis Investigative Site, Paris 75010, France; Recruiting
Novartis Investigative Site, Perpignan 66046, France; Recruiting
Novartis Investigative Site, Pierre-Benite Cédex F-69495, France; Recruiting
Novartis Investigative Site, Pringy cedex 74374, France; Recruiting
Novartis Investigative Site, Rouen Cedex 1 76038, France; Withdrawn
Novartis Investigative Site, Toulouse Cedex 9 31059, France; Recruiting
Novartis Investigative Site, Vandoeuvre Les Nancy 54511, France; Recruiting
Novartis Investigative Site, Aachen 52074, Germany; Withdrawn
Novartis Investigative Site, Aschaffenburg 63739, Germany; Withdrawn
Novartis Investigative Site, Augsburg 86150, Germany; Withdrawn
Novartis Investigative Site, Augsburg 86156, Germany; Withdrawn
Novartis Investigative Site, Bad Soden 65812, Germany; Recruiting
Novartis Investigative Site, Berlin 10709, Germany; Withdrawn
Novartis Investigative Site, Berlin 13353, Germany; Withdrawn
Novartis Investigative Site, Berlin 13357, Germany; Recruiting
Novartis Investigative Site, Bonn 53119, Germany; Withdrawn
Novartis Investigative Site, Bonn 53113, Germany; Withdrawn
Novartis Investigative Site, Bonn 53105, Germany; Withdrawn
Novartis Investigative Site, Bottrop 46236, Germany; Recruiting
Novartis Investigative Site, Chemnitz 09113, Germany; Withdrawn
Novartis Investigative Site, Dresden 01127, Germany; Withdrawn
Novartis Investigative Site, Dresden 01307, Germany; Withdrawn
Novartis Investigative Site, Duesseldorf 40479, Germany; Withdrawn
Novartis Investigative Site, Eisenach 99817, Germany; Recruiting
Novartis Investigative Site, Erlangen 91054, Germany; Recruiting
Novartis Investigative Site, Frankfurt 60389, Germany; Recruiting
Novartis Investigative Site, Frankfurt 60596, Germany; Withdrawn
Novartis Investigative Site, Friedrichshafen 88045, Germany; Completed
Novartis Investigative Site, Goettingen 37073, Germany; Withdrawn
Novartis Investigative Site, Goslar 38642, Germany; Withdrawn
Novartis Investigative Site, Halle/'Saale 06120, Germany; Withdrawn
Novartis Investigative Site, Hamburg 20099, Germany; Withdrawn
Novartis Investigative Site, Hamburg 20246, Germany; Withdrawn
Novartis Investigative Site, Hamburg 20249, Germany; Withdrawn
Novartis Investigative Site, Hamburg 22081, Germany; Withdrawn
Novartis Investigative Site, Hamm 59063, Germany; Completed
Novartis Investigative Site, Hannover 30170, Germany; Withdrawn
Novartis Investigative Site, Heidelberg 69115, Germany; Withdrawn
Novartis Investigative Site, Heilbronn 74072, Germany; Recruiting
Novartis Investigative Site, Hildesheim 31135, Germany; Withdrawn
Novartis Investigative Site, Kaiserslautern 67655, Germany; Withdrawn
Novartis Investigative Site, Kassel 34119, Germany; Withdrawn
Novartis Investigative Site, Kassel 34125, Germany; Withdrawn
Novartis Investigative Site, Kiel D-24116, Germany; Withdrawn
Novartis Investigative Site, Koblenz 56068, Germany; Recruiting
Novartis Investigative Site, Köln 50937, Germany; Withdrawn
Novartis Investigative Site, Landshut 84028, Germany; Withdrawn
Novartis Investigative Site, Leer 26789, Germany; Withdrawn
Novartis Investigative Site, Lueneburg 21339, Germany; Withdrawn
Novartis Investigative Site, Magdeburg 39120, Germany; Withdrawn
Novartis Investigative Site, Marburg 35037, Germany; Withdrawn
Novartis Investigative Site, Minden 32429, Germany; Withdrawn
Novartis Investigative Site, Muelheim 45468, Germany; Withdrawn
Novartis Investigative Site, Muenster 48149, Germany; Withdrawn
Novartis Investigative Site, Mutlangen 73557, Germany; Completed
Novartis Investigative Site, Northeim 37154, Germany; Withdrawn
Novartis Investigative Site, Nuernberg 90403, Germany; Withdrawn
Novartis Investigative Site, Passau 94036, Germany; Withdrawn
Novartis Investigative Site, Potsdam 14467, Germany; Withdrawn
Novartis Investigative Site, Rehling 86508, Germany; Withdrawn
Novartis Investigative Site, Reutlingen 72764, Germany; Withdrawn
Novartis Investigative Site, Rostock 18057, Germany; Withdrawn
Novartis Investigative Site, Rostock 18107, Germany; Withdrawn
Novartis Investigative Site, Saarbruecken 66113, Germany; Withdrawn
Novartis Investigative Site, Speyer 67346, Germany; Withdrawn
Novartis Investigative Site, Stuttgart 70376, Germany; Withdrawn
Novartis Investigative Site, Ulm 89081, Germany; Withdrawn
Novartis Investigative Site, Wuerzburg 97080, Germany; Recruiting
Novartis Investigative Site, Jakarta 10430, Indonesia; Not yet recruiting
Novartis Investigative Site, Semarang 50244, Indonesia; Not yet recruiting
Novartis Investigative Site, Amman 11191, Jordan; Withdrawn
Novartis Investigative Site, Beirut 1107 2020, Lebanon; Withdrawn
Novartis Investigative Site, Beirut, Lebanon; Withdrawn
Novartis Investigative Site, Fredrikstad NO-1603, Norway; Recruiting
Novartis Investigative Site, Tromso 9038, Norway; Recruiting
Novartis Investigative Site, Trondheim 7006, Norway; Withdrawn
Novartis Investigative Site, Braga 4710-243, Portugal; Not yet recruiting
Novartis Investigative Site, Coimbra 3000-075, Portugal; Not yet recruiting
Novartis Investigative Site, Lisboa 1099 - 023, Portugal; Not yet recruiting
Novartis Investigative Site, Lisboa 1749-035, Portugal; Not yet recruiting
Novartis Investigative Site, Singapore 119228, Singapore; Recruiting
Novartis Investigative Site, Singapore 169608, Singapore; Recruiting
Novartis Investigative Site, Bratislava 85107, Slovakia; Not yet recruiting
Novartis Investigative Site, Kosice 041 90, Slovakia; Not yet recruiting
Novartis Investigative Site, Martin 036 59, Slovakia; Not yet recruiting
Novartis Investigative Site, Bangkok 10400, Thailand; Recruiting
Novartis Investigative Site, Bangkok 10700, Thailand; Recruiting
Novartis Investigative Site, Chiang Mai 50200, Thailand; Recruiting
Novartis Investigative Site, Khon Kaen 40002, Thailand; Recruiting
Novartis Investigative Site, Mannheim, Baden-Württemberg 68305, Germany; Completed
Novartis Investigative Site, Vancouver, British Columbia V5Z 1M9, Canada; Recruiting
Novartis Investigative Site, México, Distrito Federal 14000, Mexico; Not yet recruiting
Novartis Investigative Site, Monterrey, Nuevo León 64020, Mexico; Not yet recruiting
Novartis Investigative Site, Monterrey, Nuevo Léon 64000, Mexico; Not yet recruiting
Novartis Investigative Site, Hamilton, Ontario L8V 5C2, Canada; Not yet recruiting